Arbutus Biopharma Corporation
SUBSTITUTED TETRAHYDROCYCLOPENTA[C]PYRROLES, SUBSTITUTED DIHYDROPYRROLIZINES, ANALOGUES THEREOF, AND METHODS USING SAME
Last updated:
Abstract:
The present invention includes novel substituted bicyclic compounds, and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) infection and/or hepatitis D virus (HDV) infection in a patient.
Status:
Application
Type:
Utility
Filling date:
25 Jul 2019
Issue date:
17 Jun 2021